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Letters to the EditorEVIDENCE FOR EFFICACY OF
OFF-PUMP CORONARY
ARTERY BYPASS SURGERY:
FACTS AND FADS
To the Editor:
We recently read the reply to the
Editor by Benedetto and associates,1
highlighting fundamental issues con-
cerning meta-analyses. Interestingly,
in an attempt to justify that meta-
analyses of randomized controlled
trials (RCTs) are the gold standard ev-
idence to address controversial issues,
they knowingly or unknowingly claim
that ‘‘no RCT has ever confirmed the
benefits of beating-heart coronary sur-
gery implied by observational stud-
ies.’’1 Unfortunately, this claim from
learned researchers like Benedetto
and associates is contrary to the cur-
rent best available evidence.2
Off-pump coronary artery bypass
(OPCAB) surgery, since its resurgence
in the early 1990s, has remained
a highly scrutinized technique. The
past decade was an era of trials and
tribulations for OPCAB with more
than 100 RCTs, over 300 observa-
tional studies, 60 propensity score
analyses, and same number of meta-
analyses of RCTs, as well as observa-
tional and propensity matched studies
verifying every aspect and outcome
of OPCAB. There is overwhelming
evidence from both meta-analyses of
RCTs as well as propensity score anal-
yses to confirm safety and efficacy of
OPCAB.2,3 The majority of these
RCTs and meta-analyses have shown
that outcomes of OPCAB are either
comparable or superior to on-pump cor-
onary artery bypass surgery.2,3 In fact,
OPCAB is associated with reductions
in the risks for stroke (50%), atrial
fibrillation (30%), wound infection
(48%), and acute kidney injury (70%).
OPCAB also reduces transfusion and
inotrope requirements, ventilation time,
intensive care unit and hospital stays,
and in-hospital and 1-year direct
costs.2,3
There is no denying the fact that,
whereas there is abundant evidence inThe Journalfavor of OPCAB, there is also evidence
that fails to show convincing benefits of
OPCAB.4 In view of the conflicting ev-
idence, there is a need for the cardiac
surgical community to call for a forum
andmake specific recommendations. If
it is agreed that the evidence is against
OPCAB, then those performing such
procedures should stop because they
are affecting the quality of care of thou-
sands of patients worldwide.5 If, on the
other hand, it is agreed that the evidence
for benefit of OPCAB is conclusive,
then the implications are of a different
order. However, until a verdict is
reached, as responsible researchers
and physicians it is important that we
adopt an unbiased approach to analyze
the available information’s content
for consistency, coherence, and clarity,
thereby differentiating facts from fads.
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To the Editor:
We thank Raja and associates for
their comments on our recent letter toof Thoracic and Cardiovascular SurgeEditor.1 In that letter, we observed
that in observational studies comparing
radial artery versus saphenous vein
graft, the better patency rate observed
for radial artery is surely biased by
native vessel quality. Randomization
avoids this important limitation. We
stated that the dangerous effect of se-
lection bias has also emerged in obser-
vational studies reporting beating-heart
bypass advantages over on-pump sur-
gery, which were not confirmed in ran-
domized controlled trials.2 Apparently,
Raja and associates did not like the lat-
ter statement.
However, this is not a personal
point of view but a fact that every
physician may read in a widely quoted
international cardiovascular journal.2
It is obvious that in surgical series,
beating-heart bypass has been prefer-
entially adopted when good quality
target vessels were present. This
aspect has heavily biased results in
retrospective analysis even when pro-
pensity analysis was adopted.
Results coming from randomized
controlled trials that compare not
similar but ‘‘exactly’’ the same pa-
tients reached the following conclu-
sions as reported in widely quoted
journals:
 No significant difference between
off-pump and on-pump coronary
artery bypass grafting in the rate
of the 30-day composite outcome;
the overall rate of graft patency
was lower in the off-pump group
than in the on-pump group.3
 No major differences in 30-day
outcomes in high-risk patients
randomized to off-pump versus
on-pump coronary bypass surgery:
the Best Bypass Surgery Trial.4
 Coronary artery bypass grafting
performed off-pump had lower
overall graft patency rate than on-
pump. Thirty-day complications,
neuropsychologic functioning, and
1-year clinical and functional out-
comes were not statistically differ-
ent between the 2 techniques.5ry c Volume 142, Number 3 723
Letters to the EditorEvery surgeon who routinely per-
form beating-heart bypass should be
conscious about these results, make
the patients aware, and discuss with
them the opportunity to perform
beating-heart bypass.
Sometimes, journals with a low im-
pact factor tend to publish works with
less reliable conclusions.6
Karl Popper, one of the most influ-
ential philosophers of science of the
20th century, said: ‘‘If we are uncriti-
cal we shall always find what we
want: we shall look for, and find, con-
firmations, and we shall look away
from, and not see, whatever might be
dangerous to our pet theories.’’7
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SAPHENOUS VEIN HARVEST
TECHNIQUE IN THE
RANDOMIZED ON/OFF BYPASS
(ROOBY) TRIAL
To the Editor:
We read with interest the article by
Zenati and colleagues1 describing the
results of endoscopic versus open sa-
phenous vein harvest technique on
coronary artery bypass grafting
(CABG) outcomes.1 The authors per-
formed a subgroup analysis of the Ran-
domized On/Off Bypass (ROOBY)
trial, designed to evaluate differences
in clinical outcomes between patients
undergoing on- and off-pump CABG.2
Of the 2203 patients recruited into the
original trial, 1471 (66.8%) had con-
duit data recorded and 894 (40.6%)
had angiographic follow-up at 1 year.
These latter 2 groups formed the ba-
sis of the subgroup analysis, in which
the authors found inferior rates of
saphenous vein graft patency and
increased repeat revascularization
rates in the endoscopic vein harvest
(EVH) group.
This interesting article has some
limitations that should be considered.
1. Learning curve. The study began in
2002, when EVH uptake in the
United States was low (<10%).
The variability in experience
levels, the effect of the learning
curve, and the potentially low
number of cases per institution or
practitioner should be considered
when interpreting these findings.
2. Technical details. Data regarding
technical details during conduit har-
vest and intraoperative flow charac-
teristics were unfortunately not
recorded during this study and
may have an effect on graft patency.
3. Selection bias. The primary pur-
pose of the study was not to com-
pare vein harvest techniques.
Surgeons were encouraged to use
whichever harvesting technique
they preferred, and a selection
bias may exist with unmeasuredardiovascular Surgery c September 201confounders affecting surgeons’
decision to use an EVH approach.
4. Repeat revascularization rates. The
authors provide minimal insight
into the potential reasons for the
observed increased revasculariza-
tion rates in the EVH group. It is in-
teresting to note that in the whole
population studied (n ¼ 1414),
there was no difference in revascu-
larization rates between the EVH
and open vein harvest groups
(5.2% vs 3.5%, P ¼ .13). Were
the revascularizations symptom-
driven or simply the result of an
‘‘occulo-stenotic reflex’’? If the
latter is true, then indeed the clini-
cal relevance of the finding of in-
creased saphenous vein graft
occlusion in the EVH group is un-
clear. Furthermore, recent evi-
dence from a large observational
trial using both multivariable- and
propensity-adjusted analyses actu-
ally shows a survival advantage
and no increase in revasculariza-
tion rates with the EVH technique.5
5. Literature review. Finally, at least
2 important articles examining the
long-term clinical impact of EVH
were omitted in the discussion.
Our group recently published
a large observational study show-
ing no association between EVH
and midterm freedom from death
or readmission to hospital for
cardiac catheterization, repeat re-
vascularization, acute coronary
syndromes, or heart failure.3 Allen
and colleagues4 found no differ-
ence in 5-year outcomes in a small
but randomized study.
We do strongly agree with the au-
thors’ conclusions that the time has
come for a large prospective, random-
ized study examining both angio-
graphic and clinical outcomes in
patients undergoing CABG with
open or endoscopic saphenous vein
harvesting. It will be important for
such a trial to have strict protocols re-
garding EVH technique and the expe-
rience of the vein harvester, and some1
